Home Blog Page 2566

/C O R R E C T I O N — METALTECH & AUTOMEX/

In the news release, AUTOMEX PENANG 2025 LAUNCHES, PIVOTING MALAYSIA’S MANUFACTURING SECTOR TOWARD INDUSTRY 4.0 LEADERSHIP, issued 28-Aug-2025 by METALTECH & AUTOMEX over PR Newswire, we are advised by the company that the 9th paragraph, 2nd sentence, should read “The press conference was attended by YB Jagdeep Singh Deo, Penang Deputy Chief Minister II, Dato’ Seri Wong Siew Hai, President, Malaysia Semiconductor Industry Association (MSIA), Ir. Johnson Tan, President, Malaysia Automation Technology Association (MATA), Geonice Chong, Deputy Event Director of AUTOMEX Penang and representatives from the Penang Convention & Exhibition Bureau (PCEB).” rather than “The press conference was attended by YB Jagdeep Singh Deo, Penang Deputy Chief Minister II, Andrew Chan, Executive Director, Malaysia Semiconductor Industry Association (MSIA), Ir. Johnson Tan, President, Malaysia Automation Technology Association (MATA), Geonice Chong, Deputy Event Director of AUTOMEX Penang and representatives from the Penang Convention & Exhibition Bureau (PCEB).” as originally issued inadvertently. The complete, corrected release follows:

AUTOMEX PENANG 2025 LAUNCHES, PIVOTING MALAYSIA’S MANUFACTURING SECTOR TOWARD INDUSTRY 4.0 LEADERSHIP

Penang’s “Silicon Valley of the East” to Host Premier Automation and Semiconductor Showcase, Driving Advanced Manufacturing and Global Supply Chain Integration

GEORGE TOWN, Malaysia, Aug. 28, 2025 /PRNewswire/ — AUTOMEX, Malaysia’s leading exhibition for automation and manufacturing technology, is set to make its highly anticipated debut in Penang from 4–6 November 2025 at the Setia SPICE Convention Centre.  The strategic expansion marks a major milestone for AUTOMEX. Building on its 14-year co-location with METALTECH in Kuala Lumpur and nearly three decades of driving industrial innovation nationwide, AUTOMEX is now bringing its focus to Penang – one of Southeast Asia’s most vital industrial corridors.

AUTOMEX Penang Press Conference held at KOMTAR with a special appearance by Penang Deputy Chief Minister II, YB Jagdeep Singh Deo
AUTOMEX Penang Press Conference held at KOMTAR with a special appearance by Penang Deputy Chief Minister II, YB Jagdeep Singh Deo

Recognised globally as the “Silicon Valley of the East,” Penang is home to a powerhouse ecosystem of over 300 multinational corporations and thousands of SMEs. AUTOMEX Penang will directly serve this northern manufacturing hub, showcasing the future of industrial innovation and solidifying Malaysia’s position in the global supply chain.

The inaugural event is expected to feature over 300 exhibitors and attract more than 5,000 trade visitors, offering a dynamic platform for forging partnerships, accelerating technology adoption, and driving economic growth.

AUTOMEX Penang 2025 will showcase breakthrough technologies in automation, next-generation robotics, artificial intelligence, Internet of Things (IoT) solutions, precision CNC machinery, and sustainable manufacturing. The exhibition is designed to empower manufacturers, engineers, and entrepreneurs to discover transformative solutions, forge supplier relationships, and establish cross-border partnerships that will define the future of manufacturing.

A landmark feature of this year’s event is the strategic partnership with the Malaysia Semiconductor Industry Association (MSIA). AUTOMEX Penang will co-host the prestigious Silicon Malaysia Forum (formerly the National E&E Forum), bringing together global leaders and innovators in the semiconductor sector. This strategic partnership will deepen industry integration and foster technological cooperation across the entire value chain.

“The semiconductor industry is the backbone of Penang’s economy and central to Malaysia’s competitiveness,” said Geonice Chong, Deputy Event Director of AUTOMEX Penang. “By co-hosting the Silicon Malaysia Forum at AUTOMEX Penang, we are creating a world-class platform that connects thought leaders, innovators, and investors across the E&E ecosystem. This will help Malaysia move further up the value chain into design, R&D, and advanced manufacturing, while reinforcing our place in the global semiconductor landscape.”

Penang is a vital hub for outsourced semiconductor assembly and test (OSAT) and home to many of the world’s leading technology companies. Its robust ecosystem of multinationals and SMEs contributes significantly to the global supply chain – underscoring its importance as Malaysia’s high-tech engine.

“For nearly three decades, METALTECH and AUTOMEX have championed innovation in Malaysia’s manufacturing sector. With AUTOMEX Penang 2025, we are taking this legacy forward by bringing the event to one of the nation’s most dynamic tech hubs. Our strategic partnership with MSIA positions us to significantly strengthen automation and semiconductor integration, driving Penang’s continued growth while solidifying Malaysia’s leadership position in the global digital economy,” added Geonice Chong.

A press conference was held on 28 August 2025 at the Deputy Chief Minister’s Office in Penang to officially announce the event’s launch. The press conference was attended by YB Jagdeep Singh Deo, Penang Deputy Chief Minister II, Dato’ Seri Wong Siew Hai, President, Malaysia Semiconductor Industry Association (MSIA), Ir. Johnson Tan, President, Malaysia Automation Technology Association (MATA), Geonice Chong, Deputy Event Director of AUTOMEX Penang and representatives from the Penang Convention & Exhibition Bureau (PCEB). Their presence underscores the strong industry-wide support and anticipation for AUTOMEX Penang 2025.

As Malaysia accelerates toward becoming a global Industry 4.0 powerhouse, AUTOMEX Penang 2025 will act as a catalyst for the next phase of industrial transformation in the northern region. By connecting local innovation with global opportunities, the event will position Malaysian manufacturing firmly at the cutting edge of technological advancement.

Seize the opportunity to be at the forefront of this industrial transformation. AUTOMEX Penang 2025 is your gateway to the latest technologies, key industry players, and invaluable business partnerships. Join us at AUTOMEX Penang 2025 from 4–6 November 2025 at the Setia SPICE Convention Centre.

Registration is now open. For more information or to register, please visit www.automex.com.my.

Notes to Editors:
About AUTOMEX Penang
AUTOMEX Penang is Malaysia’s premier exhibition for automation, robotics, and smart manufacturing. Building on a 14-year co-location with METALTECH in Kuala Lumpur, the event expands into PenangMalaysia’s Silicon Valley of the East” and a global hub for semiconductors and advanced manufacturing. The exhibition showcases the latest innovations in robotics, machine vision, artificial intelligence (AI), the Internet of Things (IoT), and sustainable manufacturing solutions – connecting global technology providers with multinational corporations and SMEs. By attending, industry professionals gain access to cutting-edge solutions, strategic partnerships, and insights from thought leaders. AUTOMEX Penang empowers manufacturers, engineers, and decision-makers to accelerate digital transformation, enhance competitiveness, and capture growth opportunities across the global Industry 4.0 value chain.

Medtronic executives to speak at upcoming investor conferences

GALWAY, Ireland, Aug. 29, 2025 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences:

2025 Wells Fargo Healthcare Conference
Thursday, September 4, 2025, at 8:00 a.m. EDT (7:00 a.m. CDT)
Geoff Martha, Medtronic chairman and chief executive officer, and Thierry Piéton, Medtronic executive vice president and chief financial officer, will answer questions on the company.

Morgan Stanley 23rd Annual Global Healthcare Conference
Monday, September 8, 2025, at 4:50 p.m. EDT (3:50 p.m. CDT).
Thierry Piéton, Medtronic executive vice president and chief financial officer, will answer questions on the company.

2025 Deutsche Bank Healthcare Summit
Wednesday, September 10, 2025, at 12:00 p.m. EDT (11:00 a.m. CDT)
Greg Smith, Medtronic executive vice president, enterprise operations, will answer questions on the company.

BofA Global Research Global Healthcare Conference 2025
Wednesday, September 24, 2025 at 2:10 p.m. BST (8:10 a.m. CDT)
Thierry Piéton, Medtronic executive vice president and chief financial officer, will answer questions on the company.

A live webcast for each session will be available on the date and time of each of the conferences noted above by clicking on the Investors Events link at: http://investorrelations.medtronic.com. An archive session will be available on the same webpage later in the day.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts
Erika Winkels
Public Relations
+1-763-526-8478

Ryan Weispfenning
Investor Relations
+1-763-505-4626

 

Fosun International Hosts 2025 Interim Results Presentation, Reaffirms Confidence in Future Development Driven by Innovation and Globalization

HONG KONG and SHANGHAI, Aug. 29, 2025 /PRNewswire/ — On the morning of 29 August, Fosun International held an interim results presentation in Shanghai, with attendees including Guo Guangchang, Chairman of Fosun International, Wang Qunbin, Co-Chairman of Fosun International, Chen Qiyu, Co-CEO of Fosun International, Xu Xiaoliang, Co-CEO of Fosun International, Gong Ping, CFO of Fosun International, along with numerous institutional investors and analysts.

Guo Guangchang, Chairman of Fosun International, highlighted that Fosun achieved significant breakthroughs across several business segments in the first half of 2025, particularly in the biopharmaceutical segment. Moving forward, Fosun will focus on deepening and thoroughly developing industries that it has established significant industry advantages, striving to achieve breakthroughs, accelerate growth, and ascend to the pinnacle within these mature sectors, securing a commanding global position.

In recent years, Fosun has continued to advance its business streamlining and core business-focused strategy. While divesting from a series of non-core assets, it has focused on high-growth core industries. Wang Qunbin, Co-Chairman of Fosun International, noted the importance of managing and reducing debt levels during the process of focused development. Building on ample cash flow and a reasonable debt ratio, Fosun is prioritizing growth in its core industries such as biopharmaceuticals, cultural tourism, and consumption, to strengthen its competitiveness.

Innovation is at the heart of Fosun’s ongoing strategy. In the first half of 2025, Fosun’s technology innovation strategy delivered breakthroughs, fostering a number of globally competitive innovations. Chen Qiyu, Co-CEO of Fosun International, emphasized that Fosun’s future development ultimately hinges on a strong focus on innovation. He noted that innovation must be built on a solid foundation, which involves strengthening and refining Fosun’s technology platforms. Building on these platforms, Fosun must also effectively leverage China’s local innovation capabilities. At the same time, Fosun should accelerate the development of two capabilities. The first is enhancing external collaboration and conversion capabilities to achieve efficient value realization. The second is expanding its capacity for global commercialization across international markets. This strategy, known as “Innovation + Globalization”, enables Fosun to unlock the full value of innovation through strong global commercial capabilities.

Regarding public concerns about innovative drug R&D, Guo Guangchang stated that Fosun’s current pipeline includes several innovative blockbuster products with significant global market potential, offering ample room for growth. Fosun’s pharmaceutical innovation extends beyond Henlius. It also includes Fosun Kite’s CAR-T therapy, along with innovative drugs from its established product divisions, all of which hold immense potential.

Guo Guangchang said, “I have been emphasizing to our team that we shouldn’t just sell off all our innovative drugs. Both licensing in and licensing out are important. Some products may command a high price if simply licensed out, but we are not in a rush. We should continue to advance our R&D to make these products the best in the world.”

As one of China’s largest private enterprises with the most extensive global business presence and operational capabilities, Fosun reached a new globalization milestone in the first half of 2025, with overseas revenue now accounting for 53% of the Group’s total revenue. Xu Xiaoliang, Co-CEO of Fosun International, said that Fosun has evolved from “combining China’s growth momentum with global resources” to “integrating China’s capabilities with global assets”. These capabilities are reflected in several areas: global R&D and business development, global investment, promoting Chinese culture abroad, and global operations. Fosun will continue to focus on its strategy, address challenges through development, and adopt a long-term approach to navigate economic cycles, creating greater value for shareholders and society.

Regarding the Group’s financial results in the first half of the year, Gong Ping, CFO of Fosun International, stated that Fosun’s financial strategy continues to evolve around strategic focus and steady development. In implementing this strategy, the Group has been disciplined in prioritizing its industries, concentrating resources on businesses with the potential to become industry leaders, and steadily advancing asset-light operations. Looking ahead, Fosun aims to gradually increase the proportion of overseas revenue while reducing interest-bearing debt to around RMB60 billion or less. At the same time, the Group strives to achieve RMB10 billion in both industrial operation profit and profit attributable to owners of the parent. Building on this, Fosun plans to gradually raise its dividend payout ratio and steadily raise its credit rating, ultimately achieving investment-grade rating.

In the first half of 2025, Fosun actively captured macroeconomic trends, maintained a clear strategic focus, and leveraged its strong capabilities in innovation and globalization to drive steady business development. During the Reporting Period, the Group’s total revenue reached RMB87.28 billion, industrial operation profit amounted to RMB3.15 billion, and profit attributable to owners of the parent reached RMB661.2 million. The four core subsidiaries – Fosun Pharma, Yuyuan, Fosun Insurance Portugal and Fosun Tourism Group – achieved a total revenue of RMB63.61 billion in the first half of 2025, accounting for 73% of the Group’s total revenue. As at the end of the Reporting Period, the total debt to total capital ratio stood at 53%, with debt ratio remaining at a healthy level. In May 2025, the international credit rating agency S&P affirmed Fosun’s credit metrics and maintained its rating outlook as “Stable”.

Lifezoom Updates: Refining Efficient Light Therapy Products Based on Customer Insights

NEW YORK, Aug. 29, 2025 /PRNewswire/ — Since its launch, Lifezoom‘s light therapy devices have steadily become a promising contender in the industry. However, users’ feedback revealed that the original single blue light mode is primarily suitable for short-term use, which highlights the limited benefits of blue light, with most customers calling for higher efficiency at specific wavelengths.

As Lifezoom‘s CEO mentioned, “User feedback is our most important guide. In this instance, we acted quickly to enhance the red light wand, reflecting Lifezoom’s core philosophy of putting user needs at the center.” In response to customers’ needs, an update of the red light therapy wand will be launched. The following sections will provide detailed information about Lifezoom’s upcoming product updates, as well as the products that have also been developed based on customer feedback.

The Handheld Red Light Wand and the Veyra Series from Lifezoom differ in product size, but both offer flexible and practical functionality, providing users with effective, targeted treatment for localized areas and supporting a variety of health needs, including wound healing and relief from muscle soreness.
The Handheld Red Light Wand and the Veyra Series from Lifezoom differ in product size, but both offer flexible and practical functionality, providing users with effective, targeted treatment for localized areas and supporting a variety of health needs, including wound healing and relief from muscle soreness.

Red Light Therapy Wand: Enhanced Through User Feedback

The previous version of the Handheld Light Therapy Wand by Lifezoom proved to be an excellent product for those seeking improvement in acute skin conditions, such as acne. Yet, many users also requested the addition of anti-aging and tissue-repair effects alongside anti-inflammatory benefits. The idea of the red light therapy wand originated from user feedback on the previous device iteration.

After carefully reviewing and summarizing customer feedback, Lifezoom’s decision-makers, together with R&D engineers, have planned to replace the original 460 nm blue-only setting with a combined red and near-infrared mode. This change was made based on customer feedback: the new red + near-infrared protocol will increase tissue penetration and can efficiently promote rapid wound healing and tissue repair. [1]

Precision Care: Key Features of the Red Light Therapy Wand

The new Red Light Therapy Wand by Lifezoom will be optimized to further enhance its therapeutic efficacy by utilizing two wavelengths for treatment:

  • Red light (660nm). Mainly used to promote superficial tissue repair, healing, and shows significant anti-aging effects.[2]
  • Near-infrared light (850nm). Light of this spectrum can penetrate biological objects much deeper than other parts of the spectrum, thereby improving deep-tissue healing and repair.[1]

Veyra Curved Light Series: Efficient Healing at Home

The Veyra Curved Light Series is a tangible demonstration of Lifezoom’s swift response — and more importantly, of its proactive attention to users’ demands. The device delivers targeted therapeutic effects for localized areas, similar to those of the Red Light Therapy Wand, but it is more effective, faster, and suitable for much larger areas of skin. Featuring 96 high-power LEDs mounted in a curved frame, the Veyra Curved Light Series can be placed anywhere in the house, or applied to specific parts of the body (e.g., the belly). The following light spectrum is responsible for its healing effects:

Thanks to its ergonomic design and set of stands, the Veyra Curved Light Series device can be placed near a bed, on a work desk, or on a couch. As a result, users have an excellent opportunity to incorporate red light therapy into their daily routine, without needing to focus excessively on a single session. The user friendly interface, the one button power, and the timer adjustments make the device easy to start and operate. At the same time, these features allow users to continue their routine tasks while enjoying a full scale red light therapy session.

Veyra Curved Light Series devices have proven to be a great additional solution for those who struggle with chronic pain, and they can also be handy for sports enthusiasts and for those seeking to relieve muscle pain. Sleep-deprived users can also benefit from red light therapy, which may help reduce anxiety and negative emotions associated with lack of sleep.[3] In general, Veyra Curved Light Series devices will be a great, easy-to-use, and effective solution for all those who struggle to maintain a healthy lifestyle at home.

To learn more about the detailed specifications of Lifezoom’s products and stay updated on future releases, please visit the official Lifezoom website or the Lifezoom store on Amazon.

Aspiration of Lifezoom: Built for Becoming

The Veyra Series and the Red Light Wand differ in specifications and modes of use, both embody the same principle of high-performance flexibility within their categories. Unlike the rigidity of mainstream red light products, Lifezoom demonstrates brand vitality through its fluid, adaptive design. This vitality comes not only from the dedication of its R&D team but also from its attentiveness to customer feedback—addressing current needs while uncovering new and unspoken demands.

By transforming daily living into a gentle ritual of care, Lifezoom ensures that clinical-grade insights are no longer complex, and wellness tools offer support rather than burden. In this vision, Lifezoom is built for becoming a brand that evolves with its users, enabling them to continuously grow into the healthiest and most empowered version of themselves.

Media Contact: Joey, marketing@lifezoom.tech

References:

  1. Balbinot, G. S., et al. (2021). Photobiomodulation, Cells of Connective Tissue and Repair. MDPI. https://www.mdpi.com/2304-6732/9/9
  2. Zhang, G., et al. (2015). Effect of 660 nm Light‐Emitting Diode on the Wound Healing in Fibroblast-Like Cell Lines. BioMed Research International. https://doi.org/10.1155/2015/916838 
  3. Leal Junior, E. C., et al. (2015). “Effect of 660 nm Light-Emitting Diode on the Wound Healing in Fibroblast-Like Cell Lines.” BioMed Research International. https://pmc.ncbi.nlm.nih.gov/articles/PMC4299734
  4. Pan, R., Zhang, G., Deng, F., Lin, W., & Pan, J. (2023). Effects of red light on sleep and mood in healthy subjects and individuals with insomnia disorder. Frontiers in Psychiatry, 14, Article 1200350. https://doi.org/10.3389/fpsyt.2023.1200350

 

Wesley Methodist School Celebrates Unity, Patriotism, and Diversity in Conjunction with National Day

Book Launch: Voices of Patriotism and Unity – The Recipe for Malaysia’s Success


KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 29 August 2025 – Wesley Methodist School launches a special commemorative book set, Anthology of Poems – Voices of Patriotism and Unity – The Recipe for Malaysia’s Success, a collection written by its teachers and students to honour the spirit of Malaysia.

The Official Book Launch by the VIPs
The Official Book Launch by the VIPs

The launch, officiated by YB Wong Kah Woh, Deputy Minister of Education, marks not only the unveiling of these inspiring works but also the celebration of a nation built on inclusivity, diversity, and unbreakable unity. YB Wong, whose message is also featured in the book, graced the occasion with his presence, underlining the significance of patriotism in shaping the future of Malaysia.

In his address, YB Wong also highlighted the importance of a holistic curriculum that develops well-rounded students. He emphasised that education should extend beyond academic achievement to include patriotism, digital and financial literacy, social-emotional learning, and entrepreneurship.

In conjunction with the National Day celebration, Wesley Methodist Schools across Peninsular Malaysia organised a series of activities to foster patriotism and unity among students and teachers:

  • Wesley Methodist School Penang (International): A Patriotic Unity Run was held symbolising shared pride and patriotism among the students and their teachers.
  • Wesley Methodist School Kuala Lumpur (Private): Students participated in choral speaking, sajak recitation, patriotic singing, and came dressed in traditional attire to showcase Malaysia’s cultural richness.
  • Wesley Methodist School Klang (Private): The school highlighted cultural inclusion through song and dance performances, traditional games, and team activities such as coconut bowling, encouraging camaraderie and festive spirit.
Penang school commemorated Malaysia’s National Day by uniting students and teachers in a spirit of togetherness and patriotism.
Penang school commemorated Malaysia’s National Day by uniting students and teachers in a spirit of togetherness and patriotism.
KL school students lit up the stage with a vibrant Merdeka performance, celebrating unity and culture
KL school students lit up the stage with a vibrant Merdeka performance, celebrating unity and culture

These meaningful activities complemented the book launch, reflecting Wesley Methodist Schools’ ongoing commitment to nurturing not only academic growth but also national identity, values of inclusivity, and love for the country.

For more information about the books or Wesley Methodist School, please contact:
+603-7956 5310 / +603-7957 7746.

Hashtag: #Merdeka2025 #StrongerTogetherMY #UnityInDiversity #FaithHopeUnity #BuildingTheNationTogether #CelebratingMalaysia #VoicesOfUnity #HarmonyAndHope #PatriotismInAction #BanggaJadiAnakMalaysia #CintaTanahAir

The issuer is solely responsible for the content of this announcement.

Wesley Methodist School

Wesley Methodist School (WMS) provides a well-rounded, character-driven education that nurtures the mind, body, and spirit. Rooted in Christian values, our holistic approach combines academic excellence with strong character formation, instilling confidence, resilience, and integrity in every student.

Guided by our core values of God-centredness, Integrity, Respect for Life, and Excellence with Humility, we prepare students to thrive in life and make a positive impact on society.

/C O R R E C T I O N — Arclin/

In the news release, Arclin Enters into Definitive Agreement to Acquire Aramids Business, including Kevlar® and Nomex® Brands, from DuPont™, issued 29-Aug-2025 by Arclin over PR Newswire, we are advised by the company that the following contact information should be made available: Chris Adams, Chief Legal Officer, Inquiries@Arclin.com. The complete, corrected release follows:

Arclin Enters into Definitive Agreement to Acquire Aramids Business, including Kevlar® and Nomex® Brands, from DuPont™

Acquired brands to broaden and complement Arclin’s innovation platform

ALPHARETTA, Ga., Aug. 29, 2025 /PRNewswire/ — Arclin announced today it has entered into a definitive agreement to acquire DuPont’s Aramids business, which includes the Kevlar® and Nomex® brands, for approximately $1.8 billion. The planned acquisition will expand Arclin’s portfolio to include aerospace, electrical infrastructure, electric vehicles, personal protection, and defense, while building on its strong positions in construction, infrastructure, weather and fire protection, and transportation. Arclin’s cutting-edge technologies are mission critical and drive essential products that protect and enhance everyday life. The transaction is expected to close in Q1 2026, subject to customary closing conditions and regulatory approvals. Arclin is a portfolio company of an affiliate of TJC, L.P.

“The Kevlar® and Nomex® brands have long been known for their innovation and protective qualities,” said Bradley Bolduc, President and Chief Executive Officer of Arclin. “With this planned acquisition, Arclin will unlock the potential for these brands, ushering in a new era of advanced materials that can make homes, workplaces and communities stronger, safer and more resilient.”

“DuPont is proud of the legacy of the Kevlar® and Nomex® brands,” said Lori Koch, Chief Executive Officer of DuPont. “We are confident that under Arclin’s leadership, these businesses will continue to thrive and expand their impact in new industries and applications.”

“The global footprint of the Kevlar® and Nomex® businesses presents a unique opportunity for Arclin to expand into new markets both geographically and through new products and technologies,” said Mark Glaspey, Chief Operating Officer of Arclin. “We are focused on unlocking opportunities across facilities, partners, and markets.”

“We are thrilled to add these iconic and trusted brands to the Arclin portfolio,” said Jana Wright, Arclin’s Vice President of Brand & Marketing. “The Kevlar® and Nomex® brands align with our commitment to transform protective technologies, and we are excited about the potential to further innovate and serve a broader audience with these brands.”

Transaction Highlights:

  • Arclin has entered into an agreement to acquire DuPont’s Aramids business, including the Kevlar® and Nomex® brands.
  • Expands Arclin’s portfolio with proven protective technologies trusted in personal and first responder safety.
  • Enables Arclin to leverage the highly innovative products and technologies of Kevlar®, Nomex® and Arclin.
  • Positions Arclin to create technologies and develop new products that set industry standards.
  • The acquisition includes approximately 1,900 employees who will bring decades of technical experience to Arclin.
  • Strengthens Arclin’s global market presence and accelerates entry into new geographies.
  • Transaction expected to close in Q1 2026, subject to customary closing conditions and regulatory approvals.

Piper Sandler & Company is serving as financial advisor and Kirkland & Ellis LLP is serving as legal counsel to Arclin and TJC. Centerview Partners and Goldman Sachs & Co. LLC and are serving as DuPont’s financial advisor and Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel.

About Arclin:
Arclin is a leading materials science company and manufacturer of polymer technologies, engineered products and specialized materials for the construction, agriculture, transportation infrastructure, weather & fire protection, pharmaceutical, nutrition, electronics, design, and other industries. Headquartered in Alpharetta, Georgia, Arclin has offices and manufacturing facilities throughout the U.S., Canada, and U.K. and manufactures for customers worldwide. For more information, visit www.arclin.com.

About TJC:
TJC, L.P., formerly known as The Jordan Company, has worked for more than 40 years with CEOs, founders and entrepreneurs across a range of industries including Diversified Industrials, Industrial Technology, Consumer & Healthcare, Logistics & Supply Chain and Technology & Infrastructure. With $33.2 billion of assets under management as of June 30, 2025, TJC is managed by a senior leadership team that has invested together for over 23 years on over 85 investments. TJC has offices in New York, Chicago, Miami and Stamford. For more information, please visit www.tjclp.com.

About DuPont:
DuPont™ (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

Arclin Media Contact
Chris Adams
Chief Legal Officer
Inquiries@Arclin.com

DuPontTM and all products, unless otherwise noted, denoted with TM, SM or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.

Huatai Securities’ H1 2025 Net Profit Surges Over 40%, Fueled by Tech Leadership and Global Growth


HONG KONG SAR – Media OutReach Newswire – 29 August 2025 – Huatai Securities (“Huatai” or “The Company”) today announced its financial results for the first half of 2025, demonstrating significant growth fueled by its strategic focus on technological innovation and integrated global financial services.

  • Robust Revenue Growth: Total revenue grew to RMB 20.98 billion, up 5.86% year-on-year, reinforcing its top-tier position in the industry.
  • Prominent Net Profit Growth: Net profit attributable to shareholders reached RMB 7.55 billion, a year-on-year increase of 42.16%, demonstrating high-quality development.
  • Capital Markets Leadership: The company ranked #2 in IPO underwriting by value in the A-share market, and #1 in both M&A advisory volume and ABS issuance.

Reflecting its strong performance, the company has declared an interim dividend of RMB 1.5 per 10 shares, continuing its commitment to delivering shareholder value.

As China’s economy advances through innovation and further opens to the world, the demand for sophisticated global financial services is accelerating. Huatai is dedicated to delivering world-class financial solutions with client-centric approach, combined with deep capital markets expertise and advanced digital platforms. By aligning its professional strengths with key economic priorities, the company is committed to providing the financial catalyst for China’s next phase of growth.

Powering China’s Innovation Economy

Huatai’s growth is deeply intertwined with China’s innovation-driven economy. This leadership was evident in the first half of 2025, where the company demonstrated its full-service capabilities in supporting enterprises in key sectors like technology, healthcare, and green energy:

  • Capital Markets Dominance: Equity underwriting included 14 deals valued at RMB 49 billion. The company ranked #2 in IPO underwriting by value in the A-share market and #1 by volume of disclosed regulatory-registered M&A deals as independent financial advisor.
  • Financing Innovation: Huatai underwrote 108 technology and innovation bonds totaling RMB 37.1 billion and 27 green bonds amounting to RMB 6.9 billion, channeling capital towards sustainable development.
  • Private Equity: Huatai’s private equity arm, Huatai Zijin, managed 32 active funds and completed 15 new investments in the first half, fostering regional economic growth and strategic synergies.
  • Asset Securitization and REITs: Huatai Asset Management led the industry by issuing 77 new ABS products and launching the market’s first manager-led ABS index. The company also ranked #1 in public REITs issuance, with a total scale of RMB 4.7 billion.
  • Public Finance Leadership: The company also ranked #1 in the industry for local government bond underwriting, with successful bids totaling RMB 12.8 billion, according to the Securities Association of China.

Strengthening a Seamless Cross-Border Network

To meet evolving market and client demands, Huatai is strategically enhancing its cross-border capabilities to power the globalization of Chinese enterprises. This momentum was clear in the first half of the year:

  • Strategic Licensing: Huatai secured a Mainboard Sponsor license in Singapore, a non-U.S. sovereign debt broker-dealer qualification in the U.S., and, in July 2025, an FPI license to access India’s capital markets.
  • Hong Kong Market Leadership: The company cemented its top-tier position in Hong Kong, executing multiple landmark projects and acting as a sponsor on 9 IPOs, ranking #2 by number of deals.
  • Global Research & Sales: The company’s research coverage of overseas-listed companies surged by 125%, and the number of overseas reports grew 96%.

Driving Next-Generation Finance with AI

With its “All In AI” vision, Huatai is fundamentally reshaping financial services. The company has deployed a proprietary, full-stack AI platform that leverages its deep financial data and scenario expertise to drive intelligent upgrades across investment research, advisory, banking, and operations. The next phase of Huatai’s AI strategy marks a strategic shift from isolated “scenario breakthroughs” to comprehensive “system building,” focusing on two objectives: enhancing efficiency and optimizing services.

  • Enhancing Efficiency: Internally, the company is actively pioneering the use of AI agents as a ‘digital workforce,’ moving from ‘Q&A’ interactions and content generation to sophisticated task execution. This approach aims to amplify employee capabilities and boost organizational efficiency by improving work productivity, convenience, and data insights.
  • Optimizing Services: By embracing the latest technological trends and deeply integrating AI into its financial services, Huatai is moving beyond mere efficiency gains toward a fundamental reinvention of its service model, helping to pioneer the next phase of the industry’s AI+digital development.

Looking ahead, Huatai will continue to use its deep industry insight and technological foresight to champion industrial growth and guide Chinese enterprises through an increasingly uncertain global market.

Hashtag: #HuataiSecurities

The issuer is solely responsible for the content of this announcement.

About Huatai Securities

Incorporated in April 1991, Huatai Securities is a leading technology-driven securities group in China, with a highly collaborative business model, a cutting-edge digital platform and an extensive and engaging customer base. It provides comprehensive financial services to individual and institutional clients, including wealth management, investment banking, sales and trading, investment management, among others, with a substantial international presence.

THE GROWHUB LIMITED Announces Closing of $15 Million Initial Public Offering

SINGAPORE, Aug. 29, 2025 /PRNewswire/ — THE GROWHUB LIMITED (NASDAQ: TGHL) (“GrowHub” or the “Company”), a Singapore-based company leveraging blockchain technology to enhance product traceability and authenticity, today announced the closing of its initial public offering of 3,750,000 Class A Ordinary Shares (the “Offering“) at a price of $4.00 per share (the “Offering Price“) to the public, for a total of $15 million of gross proceeds to the Company, before deducting underwriting discounts, commissions and offering expenses.

The shares began trading on the NASDAQ Stock Market LLC on August 28, 2025, under the ticker symbol “TGHL“.

Alexander Capital, L.P. (“Alexander Capital“), a full-service broker/dealer, acted as the lead book-running manager with Network 1 Financial Securities, Inc. acting as a co-underwriter for the Offering. Loeb & Loeb LLP is acting as U.S. legal counsel to the Company and Akerman LLP is acting as U.S. legal counsel to Alexander Capital for the Offering.

The Offering is being conducted pursuant to the Company’s registration statement on Form F-1 (File No. 333-286923), as amended, previously filed with and subsequently declared effective by the U.S. Securities and Exchange Commission (“SEC“) on August 25, 2025. The Offering is being made only by means of a prospectus, forming part of the registration statement. A final prospectus relating to the offering has been filed with the SEC on August 28, 2025, and is available on the SEC’s website at www.sec.gov. Copies of the final prospectus related to the Offering may be obtained from Alexander Capital, L.P., 10 Drs James Parker Blvd, Ste 202, Red Bank, New Jersey 07701, by phone at 212-687-5650 or by email at info@alexandercapitallp.com

Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more information about the Company and the Offering. This press release has been prepared for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About THE GROWHUB LIMITED

The GrowHub Limited is a Singapore-based company specializing in enhancing product traceability and authenticity within supply chains through its proprietary blockchain technology platform. GrowHub offers solutions such as blockchain traceability, anti-counterfeit measures, and carbon management to promote transparency and sustainability. GrowHub’s business comprises three main divisions: the GrowHub Platform, a revolutionary traceability blockchain technology solution, product trading facilitation offering, and IT professional services. For more information, visit https://thegrowhub.co/.

FORWARD-LOOKING STATEMENTS

Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the prospectus filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and THE GROWHUB LIMITED specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

For more information, please contact:

THE GROWHUB LIMITED Contact:
60 Paya Lebar Road
#12-37 Paya Lebar Square
Singapore 409051
+65 6993 9430
Email: media@thegrowhub.co 

Investor Relations
John Yi and Steven Shinmachi
Gateway Group, Inc.
949-574-3860
TGHL@gateway-grp.com 

Underwriter Inquiries:
Alexander Capital L.P.
10 Drs James Parker Boulevard #202,
Red Bank, NJ 07701
+1 (212) 687-5650
Email: info@alexandercapitallp.com